Fulgent Genetics, Inc. provided earning guidance for second quarter of 2022. For the second quarter of 2022, the company expects Total Revenue of approximately $125 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.05 USD | +1.37% | +0.91% | -30.65% |
May. 03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
May. 03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.65% | 592M | |
-16.71% | 8.53B | |
+64.74% | 4.31B | |
+4.70% | 2.67B | |
-2.80% | 2.62B | |
-54.53% | 1.87B | |
-19.59% | 1.66B | |
-21.51% | 1.41B | |
+15.98% | 1.2B | |
-48.13% | 1.09B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Provides Earning Guidance for Second Quarter of 2022